evalu antiarrhythm drug effect simultan analysi singl ventricular prematur contract couplet salvo clinic valu ambulatori holter electrocardiograph ecg monitor tool antiarrhythm therapi control new statist model patient group risk sudden cardiac death spontan variabl ventricular arrhythmia simultan consider singl ventricular prematur complex couplet salvo studi patient coronari heart diseas idiopath cardiomyopathi ventricular prematur complexes/h couplet last holter ecg studi between holter record patient drug-fre state mean follow-up period day maximum mean hourli valu ectop event EE ventricular prematur complex couplet salvo spontan variabl SV singl ventricular prematur complex couplet salvo SV log eeday dimens consider type arrhythmia one-dimension model simultan use type arrhythmia two- three-dimension model reduct aggrav rate suffici proof drug effect control interv week one-dimension model reduct rate ventricular prematur complex couplet salvo contrast three-dimension model rate correspond aggrav valu 